ARCHIVES

Clinical Trials: For ER+ Breast Cancer, Post-Tamoxifen, NSABP Testing Aromasin In Large Trial

This article is from The Cancer Letter archive.

Vol. 27 No. 22 | June 1, 2001

Download PDF Visit The Full Archive

Related Articles

FDA Approves New Device For Glioblastoma Multiforme

April 29, 2011

NCI Asks $955 Million In ’78; HEW Says $799 Will Be Enough

August 20, 1976

Estrogen-Only HRT Little Risk In Endometrial Cancer, GOG Study Indicates

March 26, 2004

Dana-Farber Picks Rosenthal To Direct New Center For Integrated Therapies.

June 23, 2000

NRSAs Renamed For Kirschstein.

June 21, 2002

NCI And SPORE PIs Discussing Potential Changes To Grant Program Guidelines.

September 19, 2008